November 19, 2025 — Ottawa, Ontario
The Government of Canada has announced new permanent measures to control carisoprodol, a sedative drug increasingly appearing in illegal drug markets around the world. The announcement was made today by Marjorie Michel, Minister of Health, confirming that the substance will fall under Schedule IV of the Controlled Drugs and Substances Act starting December 19, 2025.
Carisoprodol is used in some countries as a muscle relaxant, with sedative properties similar to benzodiazepines. It is not approved for medical use in Canada, but authorities have observed rising misuse internationally and evidence of the drug being diverted into illicit markets.
By placing carisoprodol under full regulatory control, the government says law enforcement and border agencies will have strengthened authority to intercept illegal shipments, investigate trafficking, and stop unauthorized distribution. Individuals involved in illegal possession, importation, or sale of the drug will face criminal penalties.
The move follows a one-year temporary emergency order introduced on February 27, 2025. During that period, border officers successfully intercepted multiple illegal shipments, reinforcing the need for permanent regulation.
This action forms part of Canada’s broader Border Plan, an initiative focused on improving border security and disrupting transnational organized crime, particularly the trafficking of dangerous substances.
Government Statements
Marjorie Michel, Minister of Health, emphasized the importance of proactive drug control measures:
“Our government will continue strengthening Canada’s drug control framework to protect public health and safety. These regulations ensure enforcement agencies have the tools they need to respond to emerging drug threats.”
Gary Anandasangaree, Minister of Public Safety, highlighted the impact on law enforcement:
“Permanent controls help stop harmful substances at the border and reinforce our commitment to combat organized crime and the illicit drug trade.”
Kevin Brosseau, Canada’s Fentanyl Czar, added:
“This sends a clear message to criminal networks—Canada remains firmly committed to eliminating illegal drugs and safeguarding communities.”
Key Points
-
Carisoprodol will be permanently added to Schedule IV under the Controlled Drugs and Substances Act.
-
The drug will also be listed under the Benzodiazepines and Other Targeted Substances Regulations.
-
Carisoprodol is not authorized for sale or medical use in Canada.
-
Temporary controls introduced in early 2025 allowed border officials to seize illegal shipments.
-
The decision aligns with findings from the World Health Organization, which documented widespread misuse and diversion of the drug worldwide.
-
The regulations support the goals of Canada’s Border Plan, which aims to strengthen cross-border safety and disrupt illegal drug trafficking.
Contact Information
Media Inquiries—Health Canada
613-957-2983
Public Inquiries
613-957-2991
1-866-225-0709